Results 91 to 100 of about 49,464 (141)

Case Report: Spindle cell metaplastic breast carcinoma. [PDF]

Front Oncol
Liu Y, Sun X, Liu J.
europepmc   +1 more source

Efficacy and safety of schedule-modified oral capecitabine/S-1 as maintenance therapy for stage N3 nasopharyngeal carcinoma after definitive chemoradiotherapy: a multicentre, single-arm phase II clinical trial. [PDF]

BMC Oral Health
Lin X, Huang L, Zheng J, Chen B, Huang C, Chen L, Pan C, Guo Q, Lin S, Zong J.   +9 more
europepmc   +1 more source

Identification of a large <i>DPYD</i> gene deletion undetected by standard genotyping in a patient with severe capecitabine-related toxicity: a case report. [PDF]

Front Pharmacol
Delcuratolo MD, Rodriquenz MG, Morelli F, Latiano TP, Muscarella LA, Caporilli S, Pasqualini L, De Santis E, Giambra V, Rinaldi A, Ciavarella G, Floris M, Murru R, Mascia A, De Mattia E, Canil G, Fania G, Pop A, Carella M, van Kuilenburg A, Cecchin E, Miscio G.   +21 more
europepmc   +1 more source

Haematological, renal and hepatic toxicity profiles of infusional 5-fluorouracil versus capecitabine in African gastrointestinal cancer patients: a retrospective cohort study. [PDF]

Ecancermedicalscience
Mazhindu TA, Ndlovu N, Borok MZ, Grimes K, Masimirembwa C.   +4 more
europepmc   +1 more source

Fulvestrant versus capecitabine as maintenance therapy in hormone receptor-positive, HER2-negative metastatic breast cancer after first-line chemotherapy (FAMILY): a multicenter, open-label, randomized, phase 3 trial. [PDF]

Signal Transduct Target Ther
Wu W, Yang Y, Chen H, Lu Y, Zeng Y, Zhao J, Du C, Lin Y, Peng P, Huang M, Zhang Y, Ouyang Q, Ding L, Cheng Z, Wen Y, Wu Z, Ye J, Ling L, Wang K, Lu Y, Zou G, Zhong J, Wang H, Lin D, Zeng, Yao C, Chen Q, Zou L, Wang S, Yu Y, Yuan Z, Wang Y, Yao H.   +32 more
europepmc   +1 more source

<i>DPYD</i>-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study. [PDF]

JCO Precis Oncol
Schettini F, Membrino A, Di Grazia G, Caltavituro A, Strina C, Milani M, Impeduglia A, Paganini L, Bosi A, Tedoldi S, Gatti M, Cervoni V, Alberio M, Giuliano M, Venturini S, Generali D.   +15 more
europepmc   +1 more source

Central Retinal Vein Occlusion in the Absence of Conventional Risk Factors Associated With Breast Carcinoma: A Case Report. [PDF]

Clin Case Rep
Danyal Barry H, Habib E, Umer Barry M, Danyal Barry M, Barkat A, Abu Dawood H.   +5 more
europepmc   +1 more source

GPI: A pan-cancer biomarker integrating genetic alterations, immune infiltration, and therapeutic response prediction. [PDF]

Glob Med Genet
Hu W, Gao Y, Li Z, Du Z, Tao J, Politis AA, Grilli FV, Di Stefano A, Wang X, Zhang J, Yin J.   +10 more
europepmc   +1 more source

Alternate-day Capecitabine Plus Trastuzumab for Frail HER2-positive Gastric Cancer: A Pilot Case Series. [PDF]

In Vivo
Odaira N, Sasaki M, Kanda J, Muneoka K.
europepmc   +1 more source

Neurotrophic-Inflammatory Imbalance and Cognitive Decline After Adjuvant Chemotherapy in Colon Cancer: A Prospective Cohort Study. [PDF]

Psychooncology
Güç ZG, Demir L, Döngelli H, Bilen İ, Uge M, Kalender ME, Alacacıoğlu A, Tarhan MO.   +7 more
europepmc   +1 more source